2 hours UroGen Pharma Announces Departure of CFO and Appointment of New CFO MarketBeat
On October 7, 2024, UroGen Pharma Ltd. (NASDAQ: URGN) entered into a separation agreement with Don Kim, resulting in his resignation from the positions of Chief Financial Officer, principal financial officer, and principal accounting officer, effective…
Nasdaq 100 · Principal Financial (PFG)